Viewing Study NCT01381705


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-06-23 @ 6:30 PM
Study NCT ID: NCT01381705
Status: COMPLETED
Last Update Posted: 2017-05-17
First Post: 2011-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CDR0000701978
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View